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Abstract
Liver homogenates could synthetize S-(isopropylcarboxymethyl) glutathione (GSIV) from
isovaleric acid and glutathione, and GSIV thus formed was cleaved into L-allo-isovalthine by
kidney glutathionase preparation. Isovaleric acid-l-C14 incorporated into GSIV without prior
cleavage by the in vitro system. The discrepancy of configuration between urinary and in vitro
synthesized isovalthine was discussed.
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Isovalthine1 3 is a new amino acid in which sulfur atom of cysteine links to
the a-carbon of isovaleric acid. Although isovalthine has been found only in the
urine of normal cats and some hypercholesterolemic patients, isovalthinuria can
be induced in some normal animals by feeding on isovaleric acid4, bile acids!'>,
some hypocholesterolemic agents!'>, glucocorticoids6, ACTHll, and epinephrine6•
As to the biosynthesis of isovalthine, a preliminary note7 showed that liver
homogenate of guinea pig could synthesize S-(iso-propylcarboxymethyl) gluta-
thione (GSIV) from isovaleric acid and glutathione, and GSIV was assumed to
be a precursor of urinary isovalthine.
This communication shows some details of GSIV synthesis in liver and its
cleavage into isovalthine in kidney.
EXPERIMENTAL AND RESULTS
1. Biosynthesis of GSIV in Liver Homogenates
One part of mammalian liver was homogenized with two parts of the
following medium: 0.1 M potassium phosphate buffer (pH 7.4), 6 mM MgCl2'
and 0.03 M nicotinamide. The homogenate was freed from cell nuclei and tissue
debris by centrifugation at 700 X g for 10 minutes.
The reaction mixture contained 50-150 mM of fatty acid which was
neutralized with KOH, 15-30 mM of reduced glutathione, 0-10 mM of ATP,
and liver homogenate (2/3 of final volume). The mixture was shaken in a
flask at 37°C for 3 hours in the air or in nitrogen, and the reaction was termi-
nated by the addition of 50% trichloroacetic acid, making the final concentration
to be 8%. The protein precipitate was removed by centrifugation and the
supernatant was treated with ethyl ether to remove trichloroacetic acid. The
water layer was adjusted to around pH 5 and transferred on a column containing
Amberlite CG-45 (acetate form). The column was washed with 3--fold resin
volume of 1 N acetic acid and eluted with 5-fold resin volume of 4 N acetic acid.
The 4 N-acetic acid eluate was evaporated to dryness in vacuum under 40°C
and the residue was taken up in a small amount of water. The water solution
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was streaked along a line at 5 cm height from the edge of some filter papers
(40 cm X 40 cm). After checking with ninhydrin on a cross-section strip of the
chromatogram, the GSIV band (Rf 0.48-0.56) was cut from the chromatogram
and extracted with distilled water. The water extract was dried in vacuum.
The dried matter was used for analysis on an amino-acid analyzer (Beckman
Modell20 B) or for the detection on paper electrophoresis6 after hydrolysis with
6 N HeI.
A typical data obtained by using 55 ml of guinea-pig liver homogenate, 10
mmoles of potassium isovalerate, 1.8 mmoles of GSH, 0.65 mmole of ATP
(final volume: 75 ml, 2.5 hr in air) is shown in Fig. 1. The final dried
matter was dissolved in 2 ml of water and one ml of the solution was analyzed
on amino-acid analyzer. (Fig. la). The chromatogram shows a new peak at
133 effluent ml. When another one ml of the solution was mixed with 0.25 /-tmole
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Fig. 1 Chromatogram of GSIV On Amino-Acid Analyzer
a. GSIV fraction synthesized in liver homogenate
b. Mixture of GSIV fraction shown in Fig. 1. a
and 0.25 ,umole of authentic GSIV.
of authentic GSIV and chromatographed on amino-acid analyzer, authentic GSIV
just overlapped on the new peak of the reaction mixture (Fig. 1b). The HW-
constant of GSIV was 24.5. The calculated amount of GSIV synthesized in
liver homogenate was 0.58 /lmole. The yields of GSIV were the same in the
air or in the nitrogen gas phase. The liver homogenates of cats, rats, and pigs
2
Acta Medica Okayama, Vol. 18 [1964], Iss. 6, Art. 4
http://escholarship.lib.okayama-u.ac.jp/amo/vol18/iss6/4
Biosynthesis of Isovalthine 335
also could synthesize GSIV. Authentic GSIV was prepared by S. Ohmori of
our laboratory and its details would be published in a separate paper.
When L-cysteine was used instead of glutathione, neither GSIV nor isovalth-
ine was detected.
When ,B-methylcrotonic acid was used in place of isovaleric acid, mainly
S-(1,1-dimethy1-2-carboxyethyl}cysteine2 was formed after hydrolysis. This
t
Q..-
:r::>
..........
:r::>
~..;< ..
,.-4
.....
='""o::l--
6
- Electrophoresis
Fig. 2 An Autoradiogram of GSIV Synthesized from Isovaleric
Acid·l-CI4 and Glutathione in Liver Homogenate
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reaction might partially be a non-enzymatic reaction.
ll. Incorporation of Isovaleric acid-l-CI4 into CSIV by Liver Homo-
genates
Guinea-pig liver homogenates (50 m!), GSH (5 ml of O. 36 M solution), and
isovaleric acid-I-CH (400 mg, 593,000 cpm/ pmoles) were mixed at 37°C for 3
hours in the air. GSIV-containing fraction was prepared by the same procedure
as described in Experiment 1. The final dried matter (8.1 mg), which contained
0.53 mg of GSIV ( I .3 ,f.lmoles) as judged by amino-acid analyzer, showed 34,500
cpm. The dried matter of 0.1, 0.2, and 0.4 mg showed 441,439, and 421 cpm
per O.J mg respectively, So the dried matter was assumed to have about 4,400
cpm/mg, and 4,400 X 8.1 = 356,400 cpm in total. If the radioactivity of the
dried matter is assumed to arise from GSIV contained in it, the specific activity
of GSIV synthesized is around 672,000 cpm/mg or 274,000 cpm/ /..fmole. From
this result, it may be permissibie to consider that isovaieric acid-1-C14 is incorpo-
rated into GSIV without prior cleavage.
The GSIV fraction was developed two dimensionally on paper by the
method of UBUKA5 and the chromatogram served for autoradiography. Fuji
X-ray film Type 200 was used for this purpose. Its autoradiogram is shown
in Fig. 2.
Ill. Partial Purification of CSIV-synthesizing Enzyme
One part of guinea-pig liver was homogenized with 1.5 parts of potassium
phosphate-bicarbonate buffer (pH 8.2)8 in Waring blendor. The homogenate
was centrifuged at 1,000 X g for ]0 minutes at O°C, and the supernatant was
again centrifuged at 13,000 X g for 30 min. The final supernatant was then
fractionated into the following four fractions with ammonium sulfate: I, 0-
25%; ll, 25-4096; Ill, 40-65%; IV, 65-75%. Precipitate of each frac-
tion was dialyzed against 0.02 M potassium phosphate buffer (pH 7.2) containing
0.5 mM EDTA for 20 hr by suspending I & Il in 0.005 M KHCOs and III &
IV in 0.02 M potassium phosphate buffer.
The dialyzed fractions were tested for their GSIV-synthesizing activity as
follows. Five ml of final reaction mixture contained 60 mM tris buffer (pH 7.5),
6 mM MgCI2, 10 mM ATP, 28 mM isovaleric acid, 60 mM KHCOa, 24 mM
GSH, and 2.5-3 ml of the dialyzed enzyme solution. The reaction mixture
was shaken at 37°C for 1 hr aDd deproteinized with trichloroacetic acid. TCA
in the supernatant was removed by ethyl ether-extraction and the water layer
was hydrolyzed in 6 N HCl for 10 hr. The hydrolysate was dried in vacuum
and the residue was dissolved in water and filtered. The filtrate was transferred
on a column containing Diaion SA-lOO (Strong anion exchanger, Mitsubishi
Kasei Co. Ltd., Tokyo) which was equillibrated with 0.5 N acetic acid before
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hand. After washing the column with 0.5 N acetic acid, isovalthine was eluted
with 2 N acetic acid. The eluate was dried in vacuum and identified for isoval-
thine by the method of UBUKA8•
The results obtained were as follows. Fraction I had no GSIV-synthesizing
activity and II showed little or no activity. Fractions III & IV were both active
either in air or in nitrogen and they did not require CoA or NAD for their
activity.
IV. Cleavage of Biosynthesized GSIV into Isovalthine by Glutathionase
Glutathionase was prepared from guinea-pig kidney as described in a pre-
vious paper1U, 11. Glutathionase was finally dissoved in 0.1 M tris buffer (pH 8.0)
and the enzyme solution containing 20 mg protein per ml was used in this
experiment.
The reaction mixture (1 m}) contained 40 !.emoles of pyrophosphate buffer
(pH 8.0), 2 !.emoles of MgC12' 6t.emoles of L-methionine, 0.52 !.emoles of GSIV,
and glutathionase (11 mg protein). The mixture was incubated for one hour at
37°C in air. L-Methionine was used as an activator of glutathionase.
The reaction was terminated by the addition of 12% trichloroacetic acid to
a final concentration of 9%. After centrifugation, the deproteinized supernatant
was treated with water-saturated ethyl ether for removal of trichloroacetic acid
and the water layer corresponding to 0.25 ml of original reaction mixture was
analyzed on amino-acid analyzer.
On the analyzer chart, L-allo-isovalthine peak appeared at 184 e££1uent ml
and the amount was 0.35 !.emoles. Chemically synthesized L-allo-isovalthines
just overlapped on the isovalthine peak obtained from biosynthesized GSIV on
amino-acid analyzer or on paper electropherogram.
It is to be noted that GSIV formed in liver homogenates gives L-allo-
isovalthine after treatment with glutathionase.
DISCUSSION
GSIV synthesized in liver homogenate gives L-allo-isovalthine after treat-
ment with kidney homogenate or glutathionase preparation, the configuration
being identical with a compound synthesized from (- )-a-bromoisovaleric acid
and L-cysteine. Urinary isovalthine, however, has been reported to be L-iso-
valthine whose configuration is identical with a compound synthesized from (+)-
a-bromoisovaleric arid.:: Up to the end of 1963, only L-isovalthinew as found in the
urine of experimental animals which were fed on bile acids, hypocholesterolemic
agents, or glucocorticoids. But, since the beginning of 196~, these experimen-
tal animals excreted a mixture of L- and L-allo-isovalthine, and it was later
reconfirmed that the method used for the determination of urinary isovalthine
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never changed the configuration of L- or L-allo-isovalthine. So it should be
considered at present that the experimental animals could synthesize both L- and
L-allo-isovalthine in their body and the biosynthetic pathway of isovalthine shown
in this paper might be one of the pathways of isovalthine biosynthesis in the
animal body. Now, an attention should be called to a quite curious pheno-
menon: when isovaleric acid-I-CH or -methyl-e14 was administered to guinea pigs,
the animals excreted isovalthine containing no O· and it was proved that the
glutamic acid was most highly labeled with CH among urinary acidic amino-
acids4•12• Thus the carbon origin of isovaleric acid residue in the urinary isoval-
thine molecule still remains obscure. These discrepancies will be studied fur-
ther.
SUMMARY
Liver homogenates could synthetize S-(isopropylcarboxymethyl) glutathione
(GSIV) from isovaleric acid and glutathione, and GSIV thus formed was cJ.eaved
into L-allo-isovalthine by kidney glutathionase preparation.
Isovaleric acid-l-04 incorporated into GSIV without prior cleavage by the
in vitro system.
The discrepancy of configuration between urinary and in vitro synthesized
isovalthine was discussed.
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